Riskpilot← Back to searchSign inGet full accessMCH AB
ABBankruptOrg 5592734197General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK 12,9M
+329% vs 2023
EBITDA margin
4.3%
+120% vs 2023
Equity ratio
4.4%
Financial strength
Net profit 2024
SEK 144K
+105% vs 2023
| Revenue | SEK 12,9M | +329% |
| EBITDA | SEK 548K | +120% |
| Net profit | SEK 144K | +105% |
| Total assets | SEK 4,3M | +64% |
| Equity | SEK 190K | +313% |
| Employees | 0 | — |
Legal name
MCH AB
Org number
5592734197
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
25 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolagets skall bedriva verksamhet inom hälso- och sjukvårdsutveckling inom primärvård, specialistsjukvård samt företagshälsovård, utbildningstjänster, bemanningstjänster, rekrytering, helhetslösningar samt därmed förenlig verksamhet
Address
Email
info@liwia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 4 680 | 912 | 2 997 | 12 867 |
| Staff expenses | — | −412 | — | — |
| EBITDA | 2 604 | −444 | −2 806 | 548 |
| Depreciation & amort. | −0 | — | −123 | −116 |
| EBIT | 2 604 | −444 | −2 929 | 432 |
| Net financials | — | −0 | −91 | −288 |
| Profit before tax | 1 953 | −5 | −2 809 | 144 |
| Tax | −418 | — | −0 | −0 |
| Net profit | 1 535 | −5 | −2 809 | 144 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 3 714 | 2 227 | 2 608 | 4 285 |
| Equity | 1 560 | 1 555 | 46 | 190 |
| Long-term debt | 0 | 4 | 2 000 | 2 722 |
| Short-term debt | 1 503 | 457 | 562 | 1 373 |
| Total debt | 1 503 | 461 | 2 562 | 4 095 |
EBITDA margin
4.3%
This company
15.8%
Market median
-73% vs market
20212024
Equity ratio
4.4%
This company
38.2%
Market median
-88% vs market
20212024
Return on equity
75.8%
This company
18.4%
Market median
+312% vs market
20212024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20212024
Asset turnover
3.00×
This company
1.12×
Market median
+168% vs market
20212024
Debt / equity
21.55×
This company
0.62×
Market median
-3376% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JA External Signatory | External Signatory | 2025 |
| Former (1) | ||
WJ Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MCH AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jasmin Alm | External Signatory | 0 companies |
| Willy José Nelson Lourenco Calling | Chief Executive Officer | 0 companies |
| Rickard Malmgren | Deputy Board Member | 0 companies |
| Fredrik Malmgren | Board of Directors | 0 companies |